急诊与门诊疑似脓毒症患者早期抗菌治疗对临床结局的影响:一项前瞻性队列研究
该前瞻性队列研究纳入2022年5月1日至2023年7月31日浙江省台州医院急诊科收治的143例疑似脓毒症患者,按入院至抗菌药物给药时间分为早期组(0-1小时,66例)和延迟组(>1小时,77例)。两组基线特征、血管活性药物使用率、机械通气时间、ICU住院时间、总住院时间及28天死亡率(18.2% vs 20.8%)、多重耐药率、脓毒症确诊率均无显著差异,Kaplan-Meier生存曲线也无差异(χ²=2.528,P=0.112)。多因素Cox回归显示血管活性药物使用(HR=2.465,95%CI 1.019-5.961,P=0.045)和气管插管(HR=5.516,95%CI 2.195-13.858,P<0.001)是28天死亡的独立危险因素。亚组分析中各亚组早期抗菌治疗均未显示改善预后的优势。结论认为早期抗菌治疗未改善急诊与门诊疑似脓毒症患者的预后。
要点
- 143例疑似脓毒症患者中,早期组(0-1小时)66例与延迟组(>1小时)77例的28天死亡率分别为18.2%(12/66)和20.8%(16/77),差异无统计学意义(P>0.05)。
- 两组脓毒症确诊率分别为87.9%(58/66)和88.3%(68/77),多重耐药率分别为3.0%(2/66)和2.6%(2/77),均无显著差异。
- Kaplan-Meier分析显示两组28天累积生存率无差异(Log-Rank检验χ²=2.528,P=0.112)。
- 多因素Cox回归显示血管活性药物使用(HR=2.465,95%CI 1.019-5.961,P=0.045)和气管插管(HR=5.516,95%CI 2.195-13.858,P<0.001)是28天死亡的独立危险因素。
- 按年龄(<60岁/≥60岁)、SOFA评分(<6/≥6)、休克指数(<1/≥1)及是否确诊脓毒症分亚组,早期抗菌治疗均未显示改善预后的优势。
适用人群与场景
- 2022年5月1日至2023年7月31日浙江省台州医院急诊科收治的疑似脓毒症患者,共143例纳入分析。
研究设计与关键结果
- 前瞻性队列研究,纳入143例疑似脓毒症患者,早期组(入院至抗菌药物给药0-1小时)66例,延迟组(>1小时)77例。
- 两组基线特征(年龄、性别、生命体征、实验室指标、疾病严重程度评分)及临床结局(血管活性药物使用率、机械通气时间、ICU住院时间、总住院时间)均无显著差异。
- 28天死亡率早期组18.2%(12/66)vs 延迟组20.8%(16/77),多重耐药率3.0%(2/66)vs 2.6%(2/77),脓毒症确诊率87.9%(58/66)vs 88.3%(68/77),均P>0.05。
- Kaplan-Meier生存曲线显示两组28天累积生存率无差异(Log-Rank检验χ²=2.528,P=0.112)。
- 多因素Cox回归显示血管活性药物使用(HR=2.465,95%CI 1.019-5.961,P=0.045)和气管插管(HR=5.516,95%CI 2.195-13.858,P<0.001)是28天死亡的独立危险因素。
- 亚组分析:年龄<60岁HR=1.214(95%CI 0.535-2.751,P=0.643),≥60岁HR=2.085(95%CI 0.233-18.668,P=0.511);SOFA<6 HR=1.411(95%CI 0.482-4.128,P=0.530),≥6 HR=0.869(95%CI 0.292-2.587,P=0.801);休克指数<1 HR=1.095(95%CI 0.390-3.077,P=0.863),≥1 HR=1.364(95%CI 0.458-4.059,P=0.577);确诊脓毒症HR=0.943(95%CI 0.059-15.091,P=0.967),未确诊HR=1.207(95%CI 0.554-2.628,P=0.636);各亚组早期抗菌治疗均未显示改善预后的优势。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为早期抗菌治疗未改善急诊与门诊疑似脓毒症患者的预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the impact of early antimicrobial therapy on the prognosis of patients with suspected sepsis in emergency and outpatient settings.
METHODS: A prospective cohort study was conducted. Patients with suspected sepsis admitted to the emergency department of Taizhou Hospital, Zhejiang Province, from May 1, 2022, to July 31, 2023, were enrolled. Participants were divided into an early group (0-1 hour) and a delayed group (> 1 hour) according to duration from admission to antimicrobial administration. General information, initial vital signs, laboratory parameters within 24 hours after admission, disease severity scores, vasoactive drug usage, and clinical outcomes of the patient were collected. Kaplan-Meier survival curve was used to analyze 28-day survival. Multivariate Cox proportional hazards regression was performed to identify independent risk factors for prognosis of the patients with suspected sepsis in emergency and outpatient settings. Sensitivity analyses were conducted through subgroup analyses.
RESULTS: A total of 143 patients with suspected sepsis were enrolled in the analysis, with 66 patients in the early group and 77 in the delayed group. No statistically significant differences were observed in baseline characteristics (age, gender, vital signs, laboratory parameters, disease severity scores) or clinical outcomes [vasoactive drug usage rate, mechanical ventilation duration, length of intensive care unit (ICU) stay, total hospitalization duration] between the two groups. The 28-day mortality, multidrug resistance rate and sepsis confirmation rate did not differ significantly between the early group and delay group [28-day mortality: 18.2% (12/66) vs. 20.8% (16/77), multidrug resistance rate: 3.0% (2/66) vs. 2.6% (2/77), sepsis confirmation rate: 87.9% (58/66) vs. 88.3% (68/77), all P > 0.05]. Kaplan-Meier survival curve analysis showed no difference in 28-day cumulative survival between the two groups (Log-Rank test: χ2 = 2.528, P = 0.112). Multivariate Cox proportional hazards regression identified vasoactive drug usage [hazard ration (HR) = 2.465, 95% confidence interval (95%CI) was 1.019-5.961, P = 0.045] and endotracheal intubation (HR = 5.516, 95%CI was 2.195-13.858, P < 0.001) as independent risk factors for 28-day death of the patients with suspected sepsis in emergency and outpatient settings. Further exploration of the impact of early antimicrobial therapy on 28-day death in different subgroups of the patients with suspected sepsis in emergency and outpatient settings was conducted through subgroup analysis. The results showed that in the patients with different ages (< 60 years old: HR = 1.214, 95%CI was 0.535-2.751, P = 0.643; ≥ 60 years old: HR = 2.085, 95%CI was 0.233-18.668, P = 0.511), sequential organ failure assessment (SOFA) scores (< 6: HR = 1.411, 95%CI was 0.482-4.128, P = 0.530; ≥ 6: HR = 0.869, 95%CI was 0.292-2.587, P = 0.801), shock indexes (< 1: HR = 1.095, 95%CI was 0.390-3.077, P = 0.863; ≥ 1: HR = 1.364, 95%CI was 0.458-4.059, P = 0.577) and whether diagnosed with sepsis or not (yes: HR = 0.943, 95%CI was 0.059-15.091, P = 0.967; no: HR = 1.207, 95%CI was 0.554-2.628, P = 0.636) subgroups, early usage of antibiotics had not shown any advantage in improving prognosis compared with delayed usage.
CONCLUSION: Early antimicrobial therapy does not improve the prognosis of patients with suspected sepsis in emergency and outpatient settings.
参考来源
- Xu X, Shen H, Zhu W, et al. [Impact of early antimicrobial therapy on clinical outcomes in patients with suspected sepsis in emergency and outpatient settings: a prospective cohort study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40814705. doi:10.3760/cma.j.cn121430-20240718-00618
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。